The last ten years have seen dramatic changes in the landscape of medical devices. From advanced resorbable biomaterials to patient-specific implants, devices are becoming increasingly complex. As a consequence, the cost of device development and the burden of proof for safety and efficacy claims have risen dramatically.

Fueled by innovative clinical applications, imaging technologies are perpetually pushing the envelope of speed and resolution. Today it is virtually impossible to find a healthcare facility without some form of CT and/or MRI system. Furthermore, preclinical image acquisition corollaries (i.e. micro-CT, micro-MR, etc.) that were once available to only the most prestigious research institutions are now available to the commercial device market.